tickerreport.com
Positivewww.tickerreport.com ·
biofrontera bfri projected to post quarterly earnings on thursday
TAX_FNCACT_ANALYSTTAX_DISEASE_BASAL_CELL_CARCINOMATAX_FNCACT_AGENTECON_STOCKMARKET
Topic context
This topic has been covered 210029 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThis is a single-company earnings preview for Biofrontera, a biotech firm. The commercial mechanism is weak: the article only reports analyst estimates and stock price movement. No product/commodity price, supply chain, or margin channel is affected. The impact is company-specific and does not extend to the broader sector.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Biofrontera (BFRI) to report Q1 2026 earnings on May 14, 2026.
- Analysts estimate EPS loss of $0.1150 and revenue of $10.25 million.
- Previous quarter reported EPS of $0.50 and revenue of $17.10 million.
- Stock opened at $1.01, down 9.0%, market cap $12.13 million.
- Weiss Ratings downgraded stock from 'sell (e+)' to 'sell (d-).'